SCHEMBL8724347

SCHEMBL8724347

c1cn(C2=C(n3ccnc3)CCC2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.45
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
ENPP2 Q13822 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
NOTUM Q6P988 1/20 0.42
CYP2A6 P11509 1/20 0.41
CYP11B2 P19099 4/20 0.41
CYP11B1 P15538 3/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
IDO1 P14902 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8726118 0.94 CYP3A4 (0.45) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL8720924 0.86 CYP3A4 (0.38) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL8721430 0.84 CYP3A4 (0.34) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL8720945 0.84 CYP3A4 (0.38) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL8724187 0.81 CYP3A4 (0.35) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL29163972 0.81
SCHEMBL8721411 0.78 TSHR (0.51) CYP3A4LMNAMAPTCYP11B2CYP11B1
SCHEMBL8724318 0.77 CYP3A4 (0.33) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL8060377 0.74 CYP3A4 (0.43) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL8724368 0.74 CYP11B2 (0.44) CYP3A4LMNAMAPTENPP2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998000430-A1 IMIDAZOL DERIVATIVES USEFUL AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-01-08 WO disclosed